Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Lane

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Environmental Science & Technology|November 19, 2020
Comparing Machine Learning Models for Aromatase (P450 19A1)Kimberley M Zorn, Daniel H Foil, Thomas R Lane, et al.
Environmental Science & Technology|October 21, 2020
Comparison of Machine Learning Models for the Androgen ReceptorKimberley M Zorn, Daniel H Foil, Thomas R Lane, et al.
Molecular Pharmaceutics|December 29, 2021
Machine Learning Models for <i>Mycobacterium tuberculosis</i><i>In Vitro</i> Activity: Prediction and Target VisualizationThomas R Lane, Fabio Urbina, Laura Rank, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 6, 2026
MegaTrans-machine learning models for drug transporters corresponding to the FDA guidancePatricia A Vignaux, Melanie Tojong, Alexander Kyu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2026
Inhibition of equilibrative nucleoside transporters 1 and 2 by proteolysis-targeting chimeras (PROTACs)Patricia A Vignaux, Lucy J Martinez Guerrero, Renuka Raman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2025
Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2Lucy J Martinez-Guerrero, Patricia A Vignaux, Dominique O Farrera, et al.
Journal of Chemical Information and Modeling|July 21, 2021
Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever VirusVictor O Gawriljuk, Daniel H Foil, Ana C Puhl, et al.
Antiviral Research|August 18, 2020
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus diseaseThomas R Lane, Julie Dyall, Luke Mercer, et al.
Environmental Science & Technology|August 29, 2020
Machine Learning Models for Estrogen Receptor Bioactivity and Endocrine Disruption PredictionKimberley M Zorn, Daniel H Foil, Thomas R Lane, et al.
Scientific Reports|August 2, 2020
Synergistic drug combinations and machine learning for drug repurposing in chordomaEdward Anderson, Tammy M Havener, Kimberley M Zorn, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Environmental Science & Technology|November 19, 2020
Comparing Machine Learning Models for Aromatase (P450 19A1)Kimberley M Zorn, Daniel H Foil, Thomas R Lane, et al.
Environmental Science & Technology|October 21, 2020
Comparison of Machine Learning Models for the Androgen ReceptorKimberley M Zorn, Daniel H Foil, Thomas R Lane, et al.
Molecular Pharmaceutics|December 29, 2021
Machine Learning Models for <i>Mycobacterium tuberculosis</i><i>In Vitro</i> Activity: Prediction and Target VisualizationThomas R Lane, Fabio Urbina, Laura Rank, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 6, 2026
MegaTrans-machine learning models for drug transporters corresponding to the FDA guidancePatricia A Vignaux, Melanie Tojong, Alexander Kyu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2026
Inhibition of equilibrative nucleoside transporters 1 and 2 by proteolysis-targeting chimeras (PROTACs)Patricia A Vignaux, Lucy J Martinez Guerrero, Renuka Raman, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2025
Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2Lucy J Martinez-Guerrero, Patricia A Vignaux, Dominique O Farrera, et al.
Journal of Chemical Information and Modeling|July 21, 2021
Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever VirusVictor O Gawriljuk, Daniel H Foil, Ana C Puhl, et al.
Antiviral Research|August 18, 2020
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus diseaseThomas R Lane, Julie Dyall, Luke Mercer, et al.
Environmental Science & Technology|August 29, 2020
Machine Learning Models for Estrogen Receptor Bioactivity and Endocrine Disruption PredictionKimberley M Zorn, Daniel H Foil, Thomas R Lane, et al.
Scientific Reports|August 2, 2020
Synergistic drug combinations and machine learning for drug repurposing in chordomaEdward Anderson, Tammy M Havener, Kimberley M Zorn, et al.
Pageof 8